Human Beta-Amyloid (1-40) HFIP
Supplier: Anaspec Inc
AS-64128-05
AS-64128-1
103007-846EA
452.31
CAD
103007-846
103007-848
Human Beta-Amyloid (1-40) HFIP
Proteins and Peptides
Removal of any preexisting structures in lyophilized stocks of Aβ-peptide is the critical initial step for controlled aggregation studies. HFIP has been shown to break down β-sheet structure, disrupt hydrophobic forces in aggregated amyloid preparations, and promotes α-helical secondary structure. HFIP treatment of lyophilized Aβ-peptide resulted in a dense, homogeneous preparation of unaggregated peptide and samples can be stored as peptide films.
- Peptide Content: ≥ 60%
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...